1
|
Inoue O, Usui S, Goten C, Hashimuko D, Yamaguchi K, Takeda Y, Nomura A, Ootsuji H, Takashima S, Iino K, Takemura H, Sanchez-Gurmaches J, Takamura M. Single-cell transcriptomics reveals an angiogenic cell population for therapeutic angiogenesis in adipose tissue. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.3089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Therapeutic angiogenesis mediated by stem/progenitor cells is an attractive therapeutic option against cardiovascular disease (CVD). Adipose tissue (AT) can be safely obtained even in CVD patients with anti-platelet medications, and it is a readily available source of culture-expanded adipose-derived stem cells (ADSCs) for transplantation. Single-cell transcriptome enables us to screen all the surface markers at once, while conventional strategies have been limited for the number of target markers. Furthermore, gene profiling at single-cell resolution can be used for the quantification of each marker by how many favorable cells can be purified without mixing of detrimental cells.
Purpose
We aimed to identify and characterize a cell population with in vivo angiogenic potential by single-cell RNA sequencing (scRNA-seq) analysis and xenograft experiments.
Methods
We revisited scRNA-seq datasets of single cell fraction from AT, bone-marrow (BM), and umbilical-cord blood (UCB, n=6/organ) to find cell populations with pro-angiogenic potential. Next, we collected AT from CVD patients (n=23) and used multicolor flow cytometry to quantify and sort the specific populations. PBS, the specific marker-negative and unsorted ADSCs were used as controls. Xenograft models of PKH26 pre-labeled human ADSC transplantation in limb ischemia were used to evaluate the lectin capillary density, PKH+ engrafted ADSCs, and blood flow recovery.
Results
Clustering divided CD45–CD31–CD34+ progenitor fraction into 3 clusters. We identified pro-/anti-angiogenic clusters based on the expressions of well-known pro-/anti-angiogenic factors. All genes encoding cell-surface proteins were compared in this functional clustering, resulted in 17 markers screened (Fig. 1A, B). Taken together with enrichment analysis, CD271+ cells showed predominant and pro-angiogenic gene profile from the other top candidates including CD36 and CD54 (Fig. 1C, D). Next, we evaluated the number and gene profile of CD271+ cells in well-known stem cell sources including BM and UCB. Surprisingly, the number of CD271 expressing cells were significantly lower and did not show angiogenic gene profile in BM and UCB (Fig. 2A). In analysis of AT from 23 CVD patients, CD271+ cells were significantly decreased by donor insulin resistance (Fig. 2B). Cell therapy using CD271+ ADSCs demonstrated in vivo angiogenic capacity compared to those of CD271– ADSCs and PBS in limb ischemia model. Furthermore, CD271+ ADSC transplantation showed enhanced efficacy compared to unsorted ADSCs from the same donors (Fig. 2C–E).
Conclusion
In this study, we identified CD271+ cell population in AT as an angiogenic cell population through scRNA-seq analysis and cell therapy experiments. AT obtained from donors without insulin resistance would be the most suitable for CD271+ ADSC isolation. CD271+ ADSC transplantation with a promising angiogenic capacity could contribute better cell-based therapy tackling CVD.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Japan Society for the Promotion of Science (JSPS) KAKENHI (Tokyo, Japan)
Collapse
Affiliation(s)
- O Inoue
- Cincinnati Children's Hospital Medical Center, Developmental Biology , Cincinnati , United States of America
| | - S Usui
- Kanazawa University, Department of Cardiology , Kanazawa , Japan
| | - C Goten
- Kanazawa University, Department of Cardiology , Kanazawa , Japan
| | - D Hashimuko
- Kanazawa University, Department of Cardiology , Kanazawa , Japan
| | - K Yamaguchi
- Kanazawa University, Department of Cardiology , Kanazawa , Japan
| | - Y Takeda
- Kanazawa University, Department of Cardiology , Kanazawa , Japan
| | - A Nomura
- Kanazawa University, Department of Cardiology , Kanazawa , Japan
| | - H Ootsuji
- Kanazawa University, Department of Cardiology , Kanazawa , Japan
| | - S Takashima
- Kanazawa University, Department of Cardiology , Kanazawa , Japan
| | - K Iino
- Kanazawa University, Department of Cardiovascular Surgery , Kanazawa , Japan
| | - H Takemura
- Kanazawa University, Department of Cardiovascular Surgery , Kanazawa , Japan
| | - J Sanchez-Gurmaches
- Cincinnati Children's Hospital Medical Center, Developmental Biology , Cincinnati , United States of America
| | - M Takamura
- Kanazawa University, Department of Cardiology , Kanazawa , Japan
| |
Collapse
|
2
|
Inoue O, Usui S, Nomura A, Yamaguchi K, Goten C, Hamaoka T, Ootsuji H, Takashima S, Murai H, Iino K, Takemura H, Takamura M. P3495Long-term engraftment of human CD271-positive adipose-derived stem cells with pericytic and less-aged gene profile in a mouse model of hindlimb ischemia. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Therapeutic angiogenesis using adipose-derived stem cells (ADSCs) is an attractive strategy for ischemic cardiovascular diseases. We previously reported that human CD271+ population of adipose-derived stem cells (ADSCs) promoted neovascularization with enhanced engraftment in a mouse model of hindlimb ischemia. However, whether and how CD271+ ADSCs promote the long-term engraftment is still uncertain.
Purpose
We aimed to examine whether the angiogenic effect and cell engraftment capacity of CD271+ ADSCs would be sustained in long-term period. Then, comparative gene profiling between CD271+ and CD271- ADSCs were analyzed. Finally, cell proliferation and endothelial differentiation assays were conducted.
Methods
ADSCs were isolated from subcutaneous adipose tissue of 5 patients received cardiovascular surgery. CD271+ and CD271- ADSCs were sorted from CD45-CD31-CD34+ ADSCs fraction by FACS sorting (Fig. A). Cultured CD271+ and CD271- ADSCs at passage 6 were labeled by PKH26 cell linker dye and used for xenograft experiments. Briefly, athymic nude mice were subjected to hindlimb ischemia and one million of human ADSCs were injected into the ischemic muscles. In control group, PBS was solely injected. At 2 and 5 weeks, neovascularization was evaluated by immunohistochemistry (capillary density using lectin perfusion). Cell engraftment was assessed by counting PKH26-positive cells. Furthermore, we compared gene profiling between CD271+ and CD271- ADSCs by microarray. Proliferative capacity was evaluated by colony-forming unit (CFU) assay with Giemsa staining. In endothelial differentiation assay, CD271+ and CD271- ADSCs were cultured in differentiation induction medium containing vascular endothelial growth factor for 2 weeks and stained with anti-human CD31 antibody.
Results
Cell therapy using CD271+ ADSCs demonstrated approximately 3-fold more enhanced neovascularization than those using CD271- ADSCs or PBS in histological analysis of capillary density at 2 weeks from cell therapy (Fig. B and C). At 5 weeks, mice treated with CD271+ ADSCs were significantly rescued from limb ischemia and this was accompanied by sustained engraftment of ADSCs (Fig. D). In microarray analysis, the differentially expressed 2167 genes were extracted to classify CD271+ and CD271- ADSCs. Pathway analysis demonstrated CD271 expression on ADSCs was associated with the pathways related to stemness and cell differentiation. Indeed, we found that genes related to cell proliferation (PI3K, Cyclin D, and Cyclin D2) were up-regulated in CD271+ ADSCs. Additionally, we found the pericytic marker nestin which was significantly up-regulated in CD271+ ADSCs. Consistent with these findings, CD271+ ADSCs were more proliferative and capable for endothelial differentiation while CD271- ADSCs were not.
FACS and cell therapy experiments
Conclusion
These results suggest that CD271+ ADSCs possess long-term engraftment and angiogenic capacity due to their less-aged and more pericytic gene profile.
Acknowledgement/Funding
Japan Society for the Promotion of Science (JSPS) KAKENHI (Tokyo, Japan) Grant Number JP16H06828
Collapse
Affiliation(s)
- O Inoue
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| | - S Usui
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| | - A Nomura
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| | - K Yamaguchi
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| | - C Goten
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| | - T Hamaoka
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| | - H Ootsuji
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| | - S Takashima
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| | - H Murai
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| | - K Iino
- Kanazawa University, Department of Cardiovascular Surgery, Kanazawa, Japan
| | - H Takemura
- Kanazawa University, Department of Cardiovascular Surgery, Kanazawa, Japan
| | - M Takamura
- Kanazawa University, Department of Cardiology, Kanazawa, Japan
| |
Collapse
|
3
|
Inoue O, Usui S, Nomura A, Goten C, Hamaoka T, Ootsuji H, Takashima S, Kato T, Murai H, Furusho H, Iino K, Takemura H, Kaneko S, Takamura M. P2555Identification of the angiogenic subset of human adipose-derived stem cells by evaluation of capability to induce M2-dominant macrophage polarization in cell therapy. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p2555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|